| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dcfb1a559b3efb2244be59a6f8acb23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a04565e61289e71b09feddfecd3afef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1821035afaec1000397c34bd94c7ad76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_572f379c811ef763f6ae304e28c1bc77 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-29 |
| filingDate |
1988-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1994-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61eb55224cdf1676f4ee6f58f66420f0 |
| publicationDate |
1994-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0439453-B1 |
| titleOfInvention |
Improved method for treatment of gastrointestinal disorders |
| abstract |
The present invention provides a method for eradicating and/or preventing recurrence of gastrointestinal disorders associated with Campylobacter pylori infections, which involves the administration of a pharmaceutical composition, comprising a pharmaceutically acceptable bismuth compound with a first antibiotic and a second antibiotic. There is also provided a pharmaceutical composition for the treatment of gastrointestinal disorders associated with C. pylori, and pharmaceutical compositions for said treatment in the form of a sequential pack. |
| priorityDate |
1987-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |